Related Experiment Video
Updated: Jul 14, 2026
Müller Glia Cell Activation in a Laser-induced Retinal Degeneration and Regeneration Model in Zebrafish
Published on: October 27, 2017
Retinal pigment epithelium produces matrix metalloproteinases after laser treatment
Christina Flaxel1, John Bradle, Ted Acott
1Glaucoma Service, Casey Eye Institute, Oregon Health & Science University, 3375 SW Terwilliger Boulevard, Portland, OR 97239-4197, USA. flaxelc@ohsu.edu
Purpose:
To evaluate production of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) after panretinal photocoagulation (PRP) of human retinal pigment epithelium (RPE) explants.
Methods:
Treated explants were subjected to substrate zymography to differentiate MMP-2 from MMP-9 and dot immunoblot analysis to quantify MMP-3 and TIMP activity. Tritiated thymidine uptake by RPE cells was measured to document evidence of cellular division in the laser-treated versus control explants.
Results:
We detected MMP-2, MMP-3, and TIMP-1. MMP-2 and MMP-3 secretion increased to twice the control values. TIMP decreased until day 4 and then increased by day 6. Tritiated thymidine uptake increased 2.5-fold until day 6, returning to baseline by day 8.
Conclusion:
PRP disturbs MMP/TIMP balance, inhibiting the initiation and maintenance required for active neovascularization. The efficacy of PRP may be due to changes in the expression pattern of metalloproteinases and inhibitors. This model elucidates the possible contribution of PRP to neovascularization regression by demonstrating the effect of laser on TIMP/MMP balance. The effects of PRP may be much more complex than currently understood and most likely involve more than vascular endothelial growth factor and other ischemia-related factors.
Insights
Panretinal photocoagulation (PRP) alters matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in retinal pigment epithelium (RPE) explants. This disruption of MMP/TIMP balance may inhibit neovascularization, contributing to PRP
Area of Science:
- Ophthalmology
- Cell Biology
- Biochemistry
Background:
- Panretinal photocoagulation (PRP) is a standard treatment for proliferative diabetic retinopathy.
- The molecular mechanisms underlying PRP's efficacy, particularly its effect on neovascularization, are not fully understood.
- Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) play crucial roles in tissue remodeling and neovascularization.
Purpose of the Study:
- To investigate the production of MMPs and TIMPs in human retinal pigment epithelium (RPE) explants following PRP.
- To assess the impact of PRP on RPE cell proliferation.
Main Methods:
- Human RPE explants were subjected to PRP.
- Substrate zymography was used to differentiate and analyze MMP-2 and MMP-9.
- Dot immunoblot analysis quantified MMP-3 and TIMP activity.
- Tritiated thymidine uptake measured RPE cell proliferation.
Main Results:
- PRP increased the secretion of MMP-2 and MMP-3 twofold compared to controls.
- TIMP levels decreased initially, then increased by day 6 post-PRP.
- RPE cell proliferation, indicated by tritiated thymidine uptake, increased 2.5-fold until day 6.
Conclusions:
- PRP significantly alters the MMP/TIMP balance in RPE explants.
- This altered balance is proposed to inhibit the initiation and maintenance of neovascularization.
- The findings suggest that changes in metalloproteinase and inhibitor expression contribute to PRP's therapeutic effect in neovascularization regression.
